Dublin, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Research and Markets
(http://www.researchandmarkets.com/research/6mzrzq/aptamers_market)
has announced the addition of the
"Global Aptamers Market Technology Trend Analysis Market Report
2013-2018" report to their offering.
The global aptamers market is valued at $287 million in 2013 and is
expected to reach $2.1 billion by 2018.
Aptamers Market - Technology Trend Analysis By Applications -
Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker
Discovery, Research Applications with Market Landscape Analysis -
Global Forecasts to 2018
Aptamers existed alongside antibodies for two decades, but their
market potential was not utilized to even a fraction of the same
degree. However, the achievement of Macugen has given a boost to
the aptamer field. The list of promising aptamers in the clinical
trials pipeline estimates that these synthetic chemical antibodies
will soon surpass monoclonal antibodies in therapeutics, diagnosis,
and imaging. With technological merits over antibodies, the
aptamers market is poised to grow at par with antibodies in the
next 10-15 years.
Though there are just approximately 60 companies (biotech and
pharmaceutical) working on aptamers, there are quite a number of
research groups focused on the diverse applications of aptamers,
particularly in studying key target molecules involved in
cardiovascular diseases, infectious diseases, and against viral
antigens. Hundreds of research articles have been published and a
large number of patents granted and filed for this
technology.
As well as a discussion on the properties of aptamers in the
technological analysis, the basics on nucleic acid aptamers,
peptide aptamers and the SELEX method for their synthesis are also
discussed. Research applications are specifically discussed
regarding aptamers use in flow cytometry, reagents and assays, mass
spectrometry and western blotting. In addition, a number of
therapeutic targets that are validated by basic research have been
displayed under the therapeutics application segment. The complete
value chain of the aptamers market is schematically represented and
the significance of each stakeholder has been briefed.
Furthermore this report assesses the investor climate by tracking
the complete investor network and collecting data on funds/grants
and investments made in
aptamers. Insights on current and future technological
investment trends have also been discussed. The adoption and
developmental potential of the aptamers technology market has been
discussed on a geographic basis, i.e. North America, Europe,
Asia-Pacific, and Rest of the world, by taking select countries
that are poised to have a greater market value during the forecast
period.
Scope of the Report
By Application
- Therapeutics
- Diagnostics
- Biosensors
- Drug discovery
- Biomarker discovery
- Research applications
By Aptamer Type
- Nucleic acid aptamers
- Peptide aptamers
Key Topics Covered:
1 Introduction
2 Executive Summary
3 Aptamers - Technology Landscape Analysis
4 Aptamers - Market Landscape Analysis
5 Technology Investment Potential
6 Aptamers - Technology Adoption And Development Potential
7 Aptamers Competitive Landscape
8 Intellectual Property And Research Strength Analysis
9 Analyst Insights And Recommendations
10 Company Profiles
- AM Biotechnologies, Llc
- Aptagen, LIC
- Aptamatrix, Inc
- Aptamer Sciences Inc
- Aptamer Solutions Ltd
- Aptares AG
- Aptusbiotech
- Base Pair Biotechnologies
- Bioapter SL
- Cd Genomics
- Integrated Dna Technologies, Inc
- Lucerna, Inc
- NOXXON Pharma AG
- Neoventures Biotechnology Inc
- OTC Biotech
- Ophthotech Corporation
- Pfizer
- Regado Biosciences, Inc
- Somalogic, Inc
- Trilink Biotechnologies, Inc
- Vivonics
For more information visit http://www.researchandmarkets.com/research/6mzrzq/aptamers_market
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector:
Biotechnology